Alvina Dor-yan Chu
Adjunct Clinical Instructor
Medicine - Immunology & Rheumatology
Stanford University
United States of America
Biography
Alvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout. She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
Research Interest
Immunology & Rheumatology
Publications
-
Furie RA, LEON G, Thomas M, Petri MA, Chu AD, (2015) A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study ANNALS OF THE RHEUMATIC DISEASES 74: 1667-1675
-
Yiu G, Rasmussen TK, Ajami B, Haddon DJ, Chu AD, Tangsombatvisit S, et al. (2016) Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1 ARTHRITIS & RHEUMATOLOGY 68: 1233-1244
